IPOs

Eyes on Asia: Ascentage’s IPO, Arrivent & Lepu, Sanofi approval, and more Eyes on Asia: Ascentage’s IPO, Arrivent & Lepu, Sanofi approval, and more

BioXconomy presents the Asia biopharma and healthcare dealmaking and financing news for the week ending 2 February.

byMillie Nelson, Editor

Feb 3, 2025

|

1 Min Read

CMO Summit in Milan, Italy

IPOs on course for recovery but does biotech need public funding anymore?IPOs on course for recovery but does biotech need public funding anymore?

Nov 12, 2024

1 Min Read

'Is the worst behind us?' Financial expert talks biotech funding 'Is the worst behind us?' Financial expert talks biotech funding

byBrian Scanlan, Dan Stanton

Oct 21, 2024

1 Min Read

Christmas present

RayzeBio: A Christmas to remember RayzeBio: A Christmas to remember

byMillie Nelson

Sep 25, 2024

1 Min Read

Eyes on Asia: UCB portfolio sale, Navigator bags $100m, Bora bulks out CDMO biz Eyes on Asia: UCB portfolio sale, Navigator bags $100m, Bora bulks out CDMO biz

byRichard Daverman

Sep 1, 2024

1 Min Read

GSK, Novartis, Calliditas among winners at LSX Awards GSK, Novartis, Calliditas among winners at LSX Awards

byMillie Nelson

Nov 16, 2023

1 Min Read

Subscribe to Our Newsletters

Stay updated and receive your insights for life sciences investment, innovation and partnering directly in your inbox.